Actively Recruiting
Neutrophil Phenotypic Profiling and Acute Lung Injury in Patients After Cardiopulmonary Bypass (CPB)
Led by Sophia Koutsogiannaki · Updated on 2024-08-23
56
Participants Needed
1
Research Sites
215 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Acute lung injury (ALI) following cardiopulmonary bypass (CPB) is a serious complication, often prolonging the length of stay in ICU and potentially dealing to mortality. The objective of this study is to assess the mechanism of CPB-mediated acute lung injury in pediatric patients.
CONDITIONS
Official Title
Neutrophil Phenotypic Profiling and Acute Lung Injury in Patients After Cardiopulmonary Bypass (CPB)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Child is younger than 12 months
- Scheduled for cardiac surgery requiring cardiopulmonary bypass
- Preoperative blood oxygen level (SpO2) is greater than 90%
You will not qualify if you...
- No parental or legal guardian consent
- Preoperative blood oxygen level (SpO2) less than 90%
- Receiving oxygen therapy before surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02115
Actively Recruiting
Research Team
S
Sophia Koutsogiannaki, PhD
CONTACT
K
Koichi Yuki, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here